Drug Type Small molecule drug |
Synonyms BAY 1753011, BAY-1753011, BAY1753011 |
Target |
Action antagonists |
Mechanism AVPR antagonists(Vasopressin receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H19Cl2F3N6O3 |
InChIKeyAZXOTZCWQDJCLY-SJCJKPOMSA-N |
CAS Registry1914998-56-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Heart Failure | Phase 2 | Austria | 29 May 2019 | |
Heart Failure | Phase 2 | Bulgaria | 29 May 2019 | |
Heart Failure | Phase 2 | Greece | 29 May 2019 | |
Heart Failure | Phase 2 | Hungary | 29 May 2019 | |
Heart Failure | Phase 2 | Israel | 29 May 2019 | |
Heart Failure | Phase 2 | Italy | 29 May 2019 | |
Heart Failure | Phase 2 | Poland | 29 May 2019 | |
Heart Failure | Phase 2 | Portugal | 29 May 2019 | |
Heart Failure | Phase 2 | Spain | 29 May 2019 |